ARGENX SE is 34.9x more valuable than Inhibrx, Inc. by market capitalization ($53.35 B vs $1.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INBX | ARGX |
|---|---|---|
| Market cap | $1.53 B | $53.35 B |
| US-listed rank | #2302 | #306 |
| Revenue (latest FY) | $1.80M | - |
| Net income (latest FY) | -$241.36M | - |
| Net margin | -13408.9% | - |
| SEC filings | 261 | 272 |
ARGENX SE is 34.9x more valuable than Inhibrx, Inc. by market capitalization ($53.35 B vs $1.53 B).
Full pages: Inhibrx, Inc. and ARGENX SE, or browse the full rankings.